Track vulnerabilities like this one.
Sign up free to get alerted when software you use is affected.
6.1
CVE-2023-47144: IBM Tivoli Application Dependency Discovery Manager 7.3.0.0 through 7.3.0.10 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI ...
CVE-2023-47144 · published 2 years ago
Summary
IBM Tivoli Application Dependency Discovery Manager 7.3.0.0 through 7.3.0.10 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted...
What to do
- Update ibm tivoli_application_dependency_discovery_manager to version 7.3.0.11 or later.
Affected software
| Vendor | Product | Affected versions |
|---|---|---|
| ibm | tivoli_application_dependency_discovery_manager |
>= 7.3.0.0, < 7.3.0.11 cpe:2.3:a:ibm:tivoli_application_dependency_discovery_manager:*:*:*:*:*:*:*:* |
Original advisory text
IBM Tivoli Application Dependency Discovery Manager 7.3.0.0 through 7.3.0.10 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI ...
IBM Tivoli Application Dependency Discovery Manager 7.3.0.0 through 7.3.0.10 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 270271.
References
- https://exchange.xforce.ibmcloud.com/vulnerabilities/270271 VDB Entry Vendor Advisory
- https://www.ibm.com/support/pages/node/7105139 Patch Vendor Advisory
Internet-facing
60 days
Internal
At next upgrade
- Not known to be exploited
- Needs hands-on effort to exploit
- Gives an attacker partial control
Type
CWE-79Cross-site Scripting (XSS)
Timeline
Published2 Feb 2024
Updated4 Nov 2026
First seen29 Sep 2026
Sources
CVE-2023-47144 · NVD
Track software like this
Free during beta